Biomarker Testing in Non-Small Cell Lung Carcinoma: Performance and Patient Outcomes

被引：0
|
作者：
Fadel, Saleh [1 ]
Chirip, Venus [2 ]
Wheatley-Price, Paul [3 ]
Reaume, Neil [3 ]
Lo, Bryan [1 ]
Chang, Nina [4 ]
Sekhon, Harmanjatinder [4 ]
Gomes, Marcio [1 ]
机构：
[1] Univ Ottawa, Ottawa Hosp, Ottawa, ON, Canada
[2] Eastern Ontario Reg Lab Assoc, Ottawa Hosp, Ottawa, ON, Canada
[3] Ottawa Hosp, Ottawa, ON, Canada
[4] Univ Ottawa, Ottawa Hosp, Eastern Ontario Reg Lab Assoc, Ottawa, ON, Canada
来源：
LABORATORY INVESTIGATION | 2021年 / 101卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
923
引用
收藏
页码：1103 / 1104
页数：2
相关论文
共 50 条
  • [1] Biomarker Testing in Non-Small Cell Lung Carcinoma: Performance and Patient Outcomes
    Fadel, Saleh
    Chirip, Venus
    Wheatley-Price, Paul
    Reaume, Neil
    Lo, Bryan
    Chang, Nina
    Sekhon, Harmanjatinder
    Gomes, Marcio
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 1103 - 1104
  • [2] Non-small cell lung carcinoma biomarker testing: the pathologist's perspective
    Brega, Elisa
    Brandao, Guilherme
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [3] Non-Small Cell Lung Cancer: Recommendations for Biomarker Testing and Treatment
    Aisner, Dara L.
    Riely, Gregory J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (5.5): : 610 - 613
  • [4] Template for Reporting Results of Biomarker Testing of Specimens From Patients With Non-Small Cell Carcinoma of the Lung
    Cagle, Philip T.
    Sholl, Lynette M.
    Lindeman, Neal I.
    Alsabeh, Randa
    Divaris, Dimitrios X. G.
    Foulis, Philip
    Lee, Gemma
    Neal, Joel W.
    Nowak, Jan A.
    Yu, Peter P.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2014, 138 (02) : 171 - 174
  • [5] Biomarker testing in non-small cell lung cancer: to move forward with quality
    Rolf Stahel
    Clinical and Translational Oncology, 2012, 14 : 321 - 322
  • [6] Biomarker Testing in Non-Small Cell Lung Cancer A Clinician's Perspective
    Bernicker, Eric
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (04) : 448 - 450
  • [7] The evolving landscape of biomarker testing for non-small cell lung cancer in Europe
    Kerr, Keith M.
    Bibeau, Frederic
    Thunnissen, Erik
    Botling, Johan
    Ryska, Ales
    Wolf, Jurgen
    Ohrling, Katarina
    Burdon, Peter
    Malapelle, Umberto
    Buttner, Reinhard
    LUNG CANCER, 2021, 154 : 161 - 175
  • [8] Access to Biomarker Testing in Patients with Advanced Non-Small Cell Lung Cancer
    Ganti, Apar
    Hirsch, Fred R.
    Wynes, Murry
    Ravelo, Arliene
    Ramalingam, Suresh
    Ionescu-Ittu, Raluca
    Pivneva, Irina
    Borghaei, Hossein
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S964 - S965
  • [9] Biomarker testing in non-small cell lung cancer: to move forward with quality
    Stahel, Rolf
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (05): : 321 - 322
  • [10] What, When, and How of Biomarker Testing in Non-Small Cell Lung Cancer
    Riely, Gregory L.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (5.5): : 686 - 688
12345